Newron Pharmaceuticals
NWRN.SW
#8195
Rank
โ‚ฌ0.18 B
Marketcap
9,48ย โ‚ฌ
Share price
-0.88%
Change (1 day)
15.35%
Change (1 year)

EPS for Newron Pharmaceuticals (NWRN.SW)

EPS in 2023: -1,00ย โ‚ฌ

According to Newron Pharmaceuticals's latest financial reports the company's current EPS (TTM) is -1,00ย โ‚ฌ. In 2023 the company made an earnings per share (EPS) of -1,00ย โ‚ฌ a decrease over its 2022 EPS that were of -0,98ย โ‚ฌ.

EPS history for Newron Pharmaceuticals from 2005 to 2023

Annual EPS

Year EPS Change
2023-1,00ย โ‚ฌ2.03%
2022-0,98ย โ‚ฌ15.39%
2021-0,85ย โ‚ฌ-31.32%
2020-1,24ย โ‚ฌ14.74%
2019-1,08ย โ‚ฌ36.6%
2018-0,79ย โ‚ฌ159.87%
2017-0,30ย โ‚ฌ-67.81%
2016-0,95ย โ‚ฌ-39.24%
2015-1,56ย โ‚ฌ107.61%
2014-0,75ย โ‚ฌ15.8%
2013-0,65ย โ‚ฌ119.91%
2012-0,29ย โ‚ฌ-66.51%
2011-0,88ย โ‚ฌ-71.49%
2010-3,09ย โ‚ฌ-10.83%
2009-3,46ย โ‚ฌ42.06%
2008-2,44ย โ‚ฌ56.53%
2007-1,56ย โ‚ฌ-52.84%
2006-3,30ย โ‚ฌ-188.53%
20053,73ย โ‚ฌ